Tuberous Sclerosis Complex: Clinical Trials

3 trials for Tuberous Sclerosis Complex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Tuberous Sclerosis Complex: new trials by email Literature Review of Tuberous Sclerosis Complex trials Research Report on Tuberous Sclerosis Complex

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
TAVT-18 (sirolimus) - Tuberous Sclerosis Complex, Epilepsy
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati52020-09-082024-05-16
Safety of Simvastatin in LAM and TSC
Simvastatin, Sirolimus Oral Product, Everolimus Oral Product - Lymphangioleiomyomatosis, Tuberous Sclerosis Complex
Phase 1 / Phase 2CompletedUniversity of Pennsylvania102014-03-012020-08-25
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Everolimus - Epilepsy, Tuberous Sclerosis Complex
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati202010-01-012017-03-13

Narrower conditions

Tuberous Sclerosis (3)  ·  Epilepsy (2)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Lymphangioleiomyomatosis (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hamartoma (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Malformations of Cortical Development (3)  ·  Malformations of Cortical Development, Group I (3)  ·  Neoplasms (3)  ·  Neoplasms, Multiple Primary (3)  ·  Neoplastic Syndromes, Hereditary (3)  ·  Nervous System Diseases (3)  ·  Nervous System Malformations (3)  ·  Neurocutaneous Syndromes (3)  ·  Neurodegenerative Diseases (3)  ·  Brain Diseases (2)

Interventions

Everolimus (2)  ·  Sirolimus (2)  ·  Simvastatin (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (2)  ·  University of Pennsylvania (1)

Countries

United States (3)

Top investigators

Darcy Krueger, M.D. Ph.D (1)  ·  Darcy Krueger, MD, PhD (1)  ·  Frank McCormack, MD (1)  ·  Maryl Kreider, MD, MSCE (1)  ·  Vera P Krymskaya, PhD, MBA (1)

Results publications

PMID 21482669, PMID 23798472, PMID 39331837